Treatment for resistant Myeloma

Israel’s Pi Therapeutics (PiTx) is developing a treatment for PI-resistant Multiple Myeloma (MM) and solid tumors. Its small molecule non-catalytic UPS inhibitors have worked in lab tests. MM is an incurable blood cancer. PiTx has just raised $19.7 million for a formal clinical proof of concept.,7340,L-3763205,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *